SUTAB

Peak

sodium sulfate, magnesium sulfate, and potassium chloride

R-Pharm US
NDAORALTABLET
Approved
Nov 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Aug 4, 2037
138 months away
Patent Expiry
Aug 4, 2037

Patent Records (4)

Patent #ExpiryTypeUse Code
10143656
Aug 4, 2037
Product
—
11033498
Aug 4, 2037
U-3164
11382864
Aug 4, 2037
U-3164
11638697
Aug 4, 2037
Product
—
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers